Item 8.01 Other Events.
On October 30, 2020, Pfizer Inc. ("Pfizer") issued a press release announcing
receipt of all required antitrust approvals and other details relating to the
anticipated closing of the proposed spin-off of Pfizer's global, primarily
off-patent branded and generic established medicines business (the
"Upjohn Business") and the subsequent proposed combination of the Upjohn
Business with Mylan N.V. A copy of the press release is attached hereto as
Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release, dated October 30, 2020
104 Cover Page Interactive Data File-The cover page XBRL tags are embedded
within the Inline XBRL Document
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses